A clinical analysis of maxillary sinus cancer

Ryuji Yasumatsu, Torahiko Nakashima, Toranoshin Ayada, Hideki Shiratsuchi, Satoshi Toh, Shizuo Komune

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)


Thirty-two patients (23 males, 9 females) with maxillary sinus cancer were treated at Kyushu University Hospital during 2000-2008. They were classified by T classification as 5 cases with T2, 13 with T3, 12 with T4a, and 2 with T4b. Between 2000 and 2003, 16 patients were given irradiation, intra-arterial 5-fluorouracil (5-FU) infusion chemotherapy, maxillectomy and postoperative irradiation. After 2004, two patients with T4b maxillary sinus cancer were treated by superselective intra-arterial chemotherapy with Cisplatin (CDDP) and Docetaxel (DOC) and irradiation. Other patients were given irradiation and chemotherapy with S-1 and intra-arterial infusion of 5-FU. The 3-year survival rate was 68.3% for all patients. The 3-year survival rate was 74.6% for patients treated after 2004, whereas it was 62.5% for patients treated between 2000 and 2003. Chemotherapy with S-1 or superselective intra-arterial chemotherapy with CDDP and DOC improved cause-specific survival rates.

Original languageEnglish
Pages (from-to)257-260
Number of pages4
JournalToukeibu Gan
Issue number3
Publication statusPublished - 2009

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology
  • Oncology


Dive into the research topics of 'A clinical analysis of maxillary sinus cancer'. Together they form a unique fingerprint.

Cite this